Dermatology Malpractice Insurance

Dermatology is often quoted under one specialty label, while the actual practice can include medical dermatology, biopsies, Mohs, repairs, pathology relationships, cosmetic work, injectables, lasers, retail products, and several entities. The first insurance question is whether the application, quote, declarations, and endorsements describe that whole operation. A specialty label, certificate, facility privilege, or shared brand does not answer that question by itself.

At a glance

Give the insurer the service inventory: medical dermatology, Mohs and repairs, pathology or laboratory work, cosmetic procedures, devices, products, sites, entities, and every clinician's role.
Read coverage by the issued terms for professional services, insured people and entities, locations, exclusions, limits, defense treatment, prior acts, and reporting. A quote is not the policy, and a certificate does not amend, extend, or alter coverage.
Keep the clinical pathway visible. A biopsy, procedure, or cosmetic treatment creates a coverage question because it creates a patient episode that must be described, documented, and completed.

Dermatology risk is not confined to the procedure room. A biopsy, Mohs repair, cosmetic treatment, laser procedure, prescription, pathology result, or device issue has a follow-up path. The practice needs to know who owns the next action and the insurer needs an accurate description of that work.

Describe the dermatology practice before comparing policies

Start with a service-and-entity inventory, not a generic specialty label. Separate medical dermatology, surgery and Mohs, pathology or laboratory relationships, cosmetic services, product sales, laser or energy-device work, and any facility or management-company role. For each, identify the clinician, employer or contractor status, location, start date, and entity that contracts, bills, or holds the record.

Then compare that inventory with the issued policy. Confirm who is an insured, what professional services and locations the form describes, whether defense costs reduce a limit, which limits or aggregates are shared, and how the form treats earlier care, claims, and reporting. An endorsement or written insurer confirmation can matter; an application, broker discussion, or certificate does not amend issued coverage.

Build the lesion and specimen pathway first

For every biopsy or specimen, make the clinical path explicit: lesion history and examination; site identification and image or diagram when clinically appropriate; collection and labeling; laboratory destination; reconciliation of outstanding specimens; report receipt; clinician review; patient communication; and next action such as excision, referral, surveillance, or repeat sampling.

Define the owner and backup at every handoff. A report in the record is not a closed loop. The system should identify what happens when a specimen is missing, a report is amended, the patient cannot be reached, or the clinician who performed the biopsy is unavailable.

If the practice owns a laboratory, employs a dermatopathologist, or bills a technical or professional pathology component, map that clinical and entity work separately. An outside laboratory does not remove the dermatology practice's need to define result receipt and patient follow-up.

Separate collection from testing. A collection-only office is not automatically a laboratory, but a site that performs patient testing can trigger California clinical-laboratory and federal CLIA requirements. Identify the testing location, test menu, applicable certificate or license, director and personnel authority, and reference-lab terms before reporting results for patient care.

Make the procedure schedule describe real medicine

List the actual clinical work: biopsies, excisions, curettage, electrosurgery, cryotherapy, Mohs stages and repairs, grafts, phototherapy, injections, lasers, IPL, energy devices, scar treatment, hair procedures, and cosmetic services. For each, identify patient selection, clinician authority, setting, anesthesia or monitoring if relevant, specimen or device process, complication plan, aftercare, and result or follow-up owner.

Do not let "medical dermatology" or "cosmetic dermatology" hide a procedure. A cash-pay service can still be medical care. A device name is not a complete clinical description.

Treat cosmetic services as patient care, not retail

For cosmetic medical services, a physician cannot serve as a nominal medical director for a lay-owned business that offers medical services. An MSO or retail business can provide administrative support, but the physician must retain ultimate approval of clinical care, records, clinical staffing competency, coding and billing decisions, and medical equipment selection.

The Board's cosmetic guidance distinguishes eligible clinicians for procedures. For Botox, it states that an MA may not inject. For the laser and IPL procedures addressed in Board guidance, it limits performers as stated there and excludes LVNs, MAs, cosmetologists, electrologists, and estheticians. Do not use "injector" or "laser technician" as a scope analysis for any other procedure or device.

For every clinician, record license, entity, service-specific authority, training and competence, assessment role, supervision or practice arrangement, availability, record access, and escalation role. Vendor training can support competence, but it does not replace legal authority or clinical oversight.

Prepare for the complication that changes the day

For every injectable, device, surgery, or procedure, the practice should know who stops care, who responds, where the patient goes, what information follows the patient, and who documents and follows up. FDA warns that accidental intravascular injection of dermal filler can cause necrosis, blindness, or stroke; it directs clinicians to stop injection when signs appear and maintain an updated treatment and referral plan. The response plan must fit the actual product, team competence, and referral path.

Use CDC safe injection practices for medication preparation and administration. Keep product identity, lot, storage, operator, device model or settings where clinically appropriate, and aftercare instructions visible in the record. Consent for care and a separate, documented authorization for marketing images are different decisions.

Let the actual anesthesia plan decide the setting question

The specialty label does not answer the facility question. The California threshold turns on anesthesia other than local anesthesia or a peripheral nerve block at doses that have the probability of placing the patient at risk of loss of life-preserving protective reflexes. If the planned care reaches that threshold, determine the permitted setting before treating patients. Do not use a marketing label or sedation shorthand to decide this.

For each site, map emergency equipment and staff, transfer or escalation route, recovery and aftercare, specimen destination, record access, and after-hours contact. A rented suite, event, mobile setting, or second office needs its own operational and regulatory review; it is not merely a new address.

Keep entities and policy questions in their own lanes

Map the professional practice, laboratory, MSO, retail company, property entity, device owner, and public brand. Then ask the carrier or broker in writing how the issued policy treats the actual clinician, entity, professional service, location, device or product activity, exclusions, limits, defense, and reporting. Do not assume a shared logo makes an entity insured or that a policy category responds to every allegation; the policy, endorsements, facts, and applicable law control.

For claims-made coverage, preserve the policy history and reporting route for each clinical period. A new device, location, clinician, cosmetic procedure, laboratory relationship, or entity can change the facts that the policy needs to evaluate. The issued terms decide whether and how the work is covered.

Test the next hard case

Run a missing pathology report, a post-Mohs bleeding call, a filler complication, a laser burn, an amended report, and a record request. If the team can identify the clinical owner, accessible record, emergency path, and policy or contract contact, the practice has built a real dermatology system rather than a procedure list.

A dermatology policy needs the full practice, not one specialty label.